Skip to main content
Home

Main navigation

  • Home
  • Chairman's Message
  • Historical Development
  • Meeting Calendar
  • Contact
  • About GHWP
    • Vision, Mission and Goals
    • Terms of Reference
    • House Rules
    • Organization Structure
    • Strategic Framework
    • Legal Entity (ASL)
    • Liaison Members of GHWP
    • Activities
    • GHWP Playbook
  • Members
    • Botswana
    • Brunei Darussalam
    • Cambodia
    • Chile
    • Chinese Taipei
    • Cuba
    • Egypt
    • Ghana
    • Hong Kong SAR, China
    • India
    • Indonesia
    • Japan
    • Jordan
    • Kazakhstan
    • Kingdom of Bahrain
    • Kingdom of Saudi Arabia
    • Kyrgyz Republic
    • Laos PDR
    • Macao SAR, China
    • Malaysia
    • Mongolia
    • Myanmar
    • Pakistan
    • People's Republic of China
    • Philippines
    • Republic of Kenya
    • Republic of Korea
    • Singapore
    • South Africa
    • State of Kuwait
    • Sultanate of Oman
    • Tanzania
    • Thailand
    • United Arab Emirates
    • Uzbekistan
    • Vietnam
    • Yemen
    • Zimbabwe
  • Technical committee
    • Work Group 1 (WG1) - Pre-Market Submission and CSDT
    • Work Group 2 (WG2) - Pre-market: IVDD
    • Work Group 3 (WG3) - Pre-market: Software as a Medical Device
    • Work Group 4 (WG4) - Post-Market
    • Work Group 5 (WG5) - Clinical Evidence for Performance and Safety
    • Work Group 7 (WG7) - Quality Management System
    • Work Group 8 (WG8) - Standards
    • Work Group 9 (WG9) - UDI & Nomenclature
    • Special Task Group-Common Evaluation Reliance Practice (CERP)
    • Terms of Reference
    • Work Plan and Target
  • GHWP Academy
    • GHWP (Guangzhou) Academy
  • News
  • Events Announcements
    • Event Sponsors
  • Events
    • Photo & Video Gallery
    • Presentations
  • Country/Region Updates
  • Documents
    • Minutes
    • Reports
    • Final Documents
    • Guidance Documents
    • Reference Document
    • Forms
    • Others
  • SADS Online
  • Trade Related Issue
  • Web Resources
  • Secretariat
  • Archive
    • Background & Objectives
    • GHWP Minutes
    • TC Minutes
  • About GHWP
    • Vision, Mission and Goals
    • Terms of Reference
    • House Rules
    • Organization Structure
    • Strategic Framework
    • Legal Entity (ASL)
    • Liaison Members of GHWP
    • Activities
    • GHWP Playbook
  • Members
    • Botswana
    • Brunei Darussalam
    • Cambodia
    • Chile
    • Chinese Taipei
    • Cuba
    • Egypt
    • Ghana
    • Hong Kong SAR, China
    • India
    • Indonesia
    • Japan
    • Jordan
    • Kazakhstan
    • Kingdom of Bahrain
    • Kingdom of Saudi Arabia
    • Kyrgyz Republic
    • Laos PDR
    • Macao SAR, China
    • Malaysia
    • Mongolia
    • Myanmar
    • Pakistan
    • People's Republic of China
    • Philippines
    • Republic of Kenya
    • Republic of Korea
    • Singapore
    • South Africa
    • State of Kuwait
    • Sultanate of Oman
    • Tanzania
    • Thailand
    • United Arab Emirates
    • Uzbekistan
    • Vietnam
    • Yemen
    • Zimbabwe
  • Technical committee
    • Work Group 1 (WG1) - Pre-Market Submission and CSDT
    • Work Group 2 (WG2) - Pre-market: IVDD
    • Work Group 3 (WG3) - Pre-market: Software as a Medical Device
    • Work Group 4 (WG4) - Post-Market
    • Work Group 5 (WG5) - Clinical Evidence for Performance and Safety
    • Work Group 7 (WG7) - Quality Management System
    • Work Group 8 (WG8) - Standards
    • Work Group 9 (WG9) - UDI & Nomenclature
    • Special Task Group-Common Evaluation Reliance Practice (CERP)
    • Terms of Reference
    • Work Plan and Target
  • GHWP Academy
    • GHWP (Guangzhou) Academy
  • News
  • Events Announcements
    • Event Sponsors
  • Events
    • Photo & Video Gallery
    • Presentations
  • Country/Region Updates
  • Documents
    • Minutes
    • Reports
    • Final Documents
    • Guidance Documents
    • Reference Document
    • Forms
    • Others
  • SADS Online
  • Trade Related Issue
  • Web Resources
  • Secretariat
  • Archive
    • Background & Objectives
    • GHWP Minutes
    • TC Minutes

Log on Here

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.
Get new captcha!
  • Reset your password

Quality Management System-Medical Devices Requirements for Distributors, Importers and Authorized Representatives

Submitted by admin on Wed, 02/01/2017 - 12:00


Please refer to the below attached with more information. 

Thank you 

  • Read more about Quality Management System-Medical Devices Requirements for Distributors, Importers and Authorized Representatives

MDSAP Assessment and Decision Process for the Recognition of an Auditing Organization

Submitted by admin on Wed, 02/01/2017 - 11:59


Please refer to the below attached with more information. 

Thank you

  • Read more about MDSAP Assessment and Decision Process for the Recognition of an Auditing Organization

Competence and Training Requirements for Auditing Organizations

Submitted by admin on Wed, 02/01/2017 - 11:58


Please refer to the below attached with more information. 

Thank you

  • Read more about Competence and Training Requirements for Auditing Organizations

Requirements for Medical Device Auditing Organizations for Regulatory Authority Recognition

Submitted by admin on Wed, 02/01/2017 - 11:57


Please refer to the below attached with more information. 

Thank you

  • Read more about Requirements for Medical Device Auditing Organizations for Regulatory Authority Recognition

MDSAP: Overview of Auditing Organization Assessment and Recognition Decision Related Processes

Submitted by admin on Wed, 02/01/2017 - 11:55


Please refer to the below attached with more information. 

Thank you

  • Read more about MDSAP: Overview of Auditing Organization Assessment and Recognition Decision Related Processes

Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) devices for the Medical Device Manufacturer or its Authorized Representative

Submitted by admin on Wed, 02/01/2017 - 11:53


Please refer to the below attached with more information. 

Thank you

  • Read more about Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) devices for the Medical Device Manufacturer or its Authorized Representative

AHWP Safety Alert Dissemination System (SADS)

Submitted by admin on Wed, 02/01/2017 - 11:51


Please refer to the below attached with more information. 

Thank you

  • Read more about AHWP Safety Alert Dissemination System (SADS)

Guidance document on Risk Categorisation of Software as a Medical Device

Submitted by admin on Wed, 02/01/2017 - 11:49


Please refer to the below attached with more information. 

Thank you

  • Read more about Guidance document on Risk Categorisation of Software as a Medical Device

Definition of the Terms “Medical Device” and “In Vitro Diagnostic (IVD) Medical Device”

Submitted by admin on Wed, 02/01/2017 - 11:47


Please refer to the below attached with more information. 

Thank you

  • Read more about Definition of the Terms “Medical Device” and “In Vitro Diagnostic (IVD) Medical Device”

Submission Dossier for Demonstrating Conformity to the Essential Principles of Safety and Performance of In Vitro Diagnostic Medical Devices

Submitted by admin on Wed, 02/01/2017 - 11:45


Please refer to the below attached with more information. 

Thank you

  • Read more about Submission Dossier for Demonstrating Conformity to the Essential Principles of Safety and Performance of In Vitro Diagnostic Medical Devices

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »
Subscribe to Guidance Documents

Powered by Drupal. Designed by Access-2-Healthcare.

2022 All rights reserved

Footer

  • Home
  • About us
  • Contact
  • Disclaimer
  • Terms of Use
  • Home
  • Chairman's Message
  • Historical Development
  • Meeting Calendar
  • Contact